Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 14Recruiting 6Unknown 3Terminated 3Active not recruiting 2Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 20Rectal Neoplasms 11Colonic Neoplasms 9Neoplasm Metastasis 7Carcinoma, Hepatocellular 6Pancreatic Neoplasms 5Stomach Neoplasms 4Recurrence 2Esophageal Neoplasms 2Adenocarcinoma Of Esophagus 2Peritoneal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Esophagogastric Cancer 1Esophageal Squamous Cell Carcinoma 1Clinical Stage I Gastric Cancer AJCC v8 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Borderline Resectable Pancreatic Adenocarcinoma 1Biliary Tract Neoplasms 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 2nilotinib 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Quality of Life 1Patient-Specific Modeling 1Oxaliplatin 1Nivolumab 1Leucovorin 1Interviews as Topic 1Fluorouracil 1Flucytosine 1Anterior Temporal Lobectomy 1AMG 337 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Gastrointestinal Neoplasms × Oxaliplatin × Clear all
NCT02344810 2023-05-25

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Eastern Cooperative Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡